About James Stefansic
James Stefansic is the chief operating officer of OmniBuds, which is developing ear-based cardiovascular monitoring technology. He runs the company's business in the United States: day-to-day operations, finance, and regulatory and clinical work. He is also a director at Raiven Healthcare. He co-founded the AI analytics company and sold it to a private equity group.
Earlier, he was senior director of corporate development at Cumberland Emerging Technologies. He found and negotiated new biopharmaceutical products and technologies, especially with academic institutions. He co-founded Pathfinder Therapeutics and served as its chief operating officer, running FDA regulatory submissions and business development. He brought in more than $17 million in venture capital and SBIR funding there. An FDA 510(k) summary for Pathfinder names him chief technology officer. He was also director of commercialization at Launch Tennessee. He began as a research assistant professor at Vanderbilt University Medical Center. He is president of the Alumni Board of Advisors at Belmont University's Jack C. Massey Graduate School of Business.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name James Stefansic in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Stefansic works with at each company, as listed on that company's latest Form D.
